“We are carefully monitoring and reviewing reports of:
- myocarditis and pericarditis following mRNA vaccines, particularly in younger age groups
- thrombosis with thrombocytopenia syndrome (TTS) following Vaxzevria (AstraZeneca)
- Guillain-Barre Syndrome (GBS) following Vaxzevria (AstraZeneca)
- immune thrombocytopenia (ITP) following Vaxzevria (AstraZeneca)”
© Commonwealth of Australia
Copyright
https://www.tga.gov.au/copyright
Permission is given for fair dealing with this material including for the purposes of private study and research and may be reproduced as permitted under the Copyright Act 1968. (A copy of the Act is available at ComLaw - external site, the legal information retrieval system owned by the Australian Attorney General’s Department). All other rights are reserved.
Any permitted reproduction made must acknowledge the Commonwealth as the source of any selected passage, extract, diagram or other information or material reproduced. Any reproduction made of the information or material must include a copy of the original copyright and disclaimer notices as set out here.